ARB-1740

N/A

Report date: 2025/04/14 15:43:05
NME

Base Information

Drug NameARB-1740
Drug Alias NameARB-1740
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceHepatitis B virus inhibitors
TargetsHepatitis B virus
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArbutus Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesArbutus Biopharma Corp
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A